Jessica Furst

Advanced Glycation Endproducts and Bone Material Strength in Type 2 Diabetes

Jessica Furst, Leonardo Bandeira, Wen-Wei Fan et al. · The Journal of Clinical Endocrinology & Metabolism · 2016 · 212 citations · Full text

Medicine, Endocrinology, Aging +16

BiRD (Biaxin [clarithromycin]/Revlimid [lenalidomide]/dexamethasone) combination therapy results in high complete- and overall-response rates in treatment-naive symptomatic multiple myeloma.

Rubén Niesvizky, David Jayabalan, Paul J. Christos et al. · Blood · 2007 · 183 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +10

Stem Cell Mobilization with Cyclophosphamide Overcomes the Suppressive Effect of Lenalidomide Therapy on Stem Cell Collection in Multiple Myeloma

Tomer M. Mark, Jessica Stern, Jessica Furst et al. · Biology of Blood and Marrow Transplantation · 2008 · 116 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Lenalidomide‐induced myelosuppression is associated with renal dysfunction: adverse events evaluation of treatment‐naïve patients undergoing front‐line lenalidomide and dexamethasone therapy

Rubén Niesvizky, Tara Naib, Paul J. Christos et al. · British Journal of Haematology · 2007 · 89 citations

Medicine, Hematology, Oncology +15

Prophylactic low-dose aspirin is effective antithrombotic therapy for combination treatments of thalidomide or lenalidomide in myeloma

Rubén Niesvizky, Déborah Martı́nez-Baños, Jessica Jalbrzikowski et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2007 · 61 citations

Medicine, Pharmacology, Pharmacotherapy +17